Related Experiment Videos
The immunopathology of pemphigus and bullous pemphigoid. 1968
The Journal of Investigative Dermatology
|April 1, 1989
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
IgG4 as the predominant IgG subclass in pemphigoides gestationis.
Journal of cutaneous pathology·2006
Cryofibrinogenemia in a patient with B-cell lymphoma.
Clinical lymphoma·2001
Linear IgA bullous dermatosis in one of two piroxicam-induced eruptions: a distinct direct immunofluorescence trend revealed by the literature.
Journal of the American Academy of Dermatology·2001
Simultaneous presence of mucous membrane pemphigoid and pemphigus vulgaris: molecular characterization of both autoantibodies.
Clinical immunology (Orlando, Fla.)·2001
A case of dermatitis herpetiformis with IgA endomysial antibodies but negative direct immunofluorescent findings.
Journal of the American Academy of Dermatology·2000
DNPH1 exerts context-dependent tumor-promoting and -repressing functions during melanoma development.
The Journal of investigative dermatology·2026
Skin Cancer Risk Stratification and Outcomes in Swedish Solid Organ Transplant Recipients.
The Journal of investigative dermatology·2026
Proteomic signature predicts the metastatic risk of primary cutaneous squamous cell carcinomas.
The Journal of investigative dermatology·2026
The AhR-TFAP2A Axis Regulates Melanosome Transport by Directly Targeting Myosin Va and Mlph.
The Journal of investigative dermatology·2026
Differential BET protein recruitment to IL6 and IL8 promoters and suppression of inflammatory and cell cycle genes by BET inhibitor in keratinocytes.
The Journal of investigative dermatology·2026
Lesional hair lipidomic signatures reveal ARA-LTB4 pathway activation and NETs formation in hidradenitis suppurativa.
The Journal of investigative dermatology·2026
Phloretin Modulates STING Ubiquitination Degradation to Restrain Dendritic Cell Overactivation and Alleviate Sjögren's Syndrome.
Pharmaceuticals (Basel, Switzerland)·2026